Inspired? If you’re an Early Career Researcher you could win a £300 grant to share your research at an academic conference. Deadlines are rolling on a monthly basis.

Apply now

Scientists building on earlier research into stem cells have managed to halt multiple sclerosis (MS) in a clinical trial, but the treatment is not suitable for patients with an advanced stage of the disease.

Read More

The dysfunction of cells' energy generators - the mitochondria - plays a key role in multiple sclerosis and offers new ways of treatment.

Read More

Mounting evidence points to a link between the make-up of the gut microbiome and multiple sclerosis (MS). Tweaking our bacterial mix can pave the way for new therapies.

Read More

Antibodies are a new alternative to anti-inflammatory drugs for curbing the progress of MS and letting patients enjoy their lives. They work by neutralising the ‘misguided’ immune cells associated with the disease.

Read More

Posts by Tag

see all